Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Cenicriviroc

Product Specifications

UNSPSC Description

Cenicriviroc (TAK-652) is an orally active, dual CCR2/CCR5 antagonist, also inhibits both HIV-1 and HIV-2, and displays potent anti-inflammatory and antiinfective activity[1].

Target Antigen

CCR; HIV

Type

Reference compound

Related Pathways

Anti-infection;GPCR/G Protein;Immunology/Inflammation

Applications

COVID-19-anti-virus

Field of Research

Infection; Endocrinology

Assay Protocol

https://www.medchemexpress.com/Cenicriviroc.html

Solubility

DMSO : 50 mg/mL (ultrasonic)|Ethanol : 2 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : < 0.1 mg/mL

Smiles

O=C(/C1=C/C2=CC(C3=CC=C(OCCOCCCC)C=C3)=CC=C2N(CC(C)C)CCC1)NC4=CC=C([S@](CC5=CN=CN5CCC)=O)C=C4

Molecular Weight

696.94

References & Citations

[1]Lefebvre E, et al. Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis. PLoS One. 2016 Jun 27;11(6):e0158156|[2]Kuwata T, et al. Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies. Antimicrob Agents Chemother. 2015 Nov 2;60(1):437-5|[3]Visseaux B, et al. Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates. PLoS One. 2015 Aug 6;10(8):e0134904|[4]Lalezari J, et al. Safety, efficacy, and pharmacokinetics of TBR-652, a CCR5/CCR2 antagonist, in HIV-1-infected, treatment-experienced, CCR5 antagonist-naive subjects. J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):118-25.|[5]Baba M, et al. TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans. Antimicrob Agents Chemother. 2005 Nov;49(11):4584-91.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-14882/Cenicriviroc-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-14882/Cenicriviroc-SDS-MedChemExpress.pdf

Clinical Information

Phase 3

CAS Number

497223-25-3

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Human Transmembrane protein C5orf28 (C5orf28), partial
MBS7073328 Inquire

Recombinant Human Transmembrane protein C5orf28 (C5orf28), partial

Ask
View Details
H-Gly-ONp Hydrochloride
sc-285941 1 g

H-Gly-ONp Hydrochloride

Ask
View Details
Frozen Tissue Sections, Cartilage
CS523349 5x 5 µm

Frozen Tissue Sections, Cartilage

Ask
View Details
AKAP2 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
11652064 1.0 µg DNA

AKAP2 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)

Ask
View Details
Olfr1238 AAV siRNA Pooled Vector
32695164 1.0 μg

Olfr1238 AAV siRNA Pooled Vector

Ask
View Details